Dillard'S (DDS) EBITDA Margin (2009 - 2026)

Dillard'S (DDS) has 18 years of EBITDA Margin data on file, last reported at 34.36% in Q2 2026.

• Quarterly EBITDA Margin rose 30.0% year-over-year to 34.36% in Q2 2026, while the trailing twelve-month figure through May 2026 was 31.14% (up 152.0% YoY) and the FY2026 annual result came in at 30.39%, up 105.0% from the prior year.
• EBITDA Margin climbed to 34.36% in Q2 2026, from 30.49% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 35.04% in Q2 2024 to a low of 10.12% in Q1 2024.
• A 5-year average of 23.74% and a median of 24.67% in 2025 frame the typical range for EBITDA Margin.
• The widest YoY moves for EBITDA Margin: up 1691 bps in 2024, down 1034 bps in 2024.
• Tracing DDS's EBITDA Margin over 5 years: stood at 17.44% in 2022, then fell by 16 bps to 14.57% in 2023, then soared by 116 bps to 31.48% in 2024, then increased by 5 bps to 33.03% in 2025, then gained by 4 bps to 34.36% in 2026.
• The last three EBITDA Margin figures came in at 34.36% (Q2 2026), 30.49% (Q1 2026), and 33.03% (Q4 2025), per Business Quant data.